Cargando…
A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI
PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255313/ https://www.ncbi.nlm.nih.gov/pubmed/34235105 http://dx.doi.org/10.2147/JHC.S316385 |
_version_ | 1783717879897653248 |
---|---|
author | Sheng, Ruofan Huang, Jing Zhang, Weiguo Jin, Kaipu Yang, Li Chong, Huanhuan Fan, Jia Zhou, Jian Wu, Dijia Zeng, Mengsu |
author_facet | Sheng, Ruofan Huang, Jing Zhang, Weiguo Jin, Kaipu Yang, Li Chong, Huanhuan Fan, Jia Zhou, Jian Wu, Dijia Zeng, Mengsu |
author_sort | Sheng, Ruofan |
collection | PubMed |
description | PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on multiphase gadoxetic acid-enhanced MRI using deep convolutional neural networks (CNN). PATIENTS AND METHODS: An internal data set of 439 patients and external data set of 71 patients with suspected HCC were included and underwent gadoxetic acid-enhanced MRI. The expert-guided LI-RADS grading system consisted of four deep 3D CNN models including a tumor segmentation model for automatic diameter estimation and three classification models of LI-RADS major features including arterial phase hyper-enhancement (APHE), washout and enhancing capsule. An end-to-end learning system comprising single deep CNN model that directly classified the LI-RADS grade was developed for comparison. RESULTS: On internal testing set, the segmentation model reached a mean dice of 0.84, with the accuracy of mapped diameter intervals as 82.7% (95% CI: 74.4%, 91.7%). The area under the curves (AUCs) were 0.941 (95% CI: 0.914, 0.961), 0.859 (95% CI: 0.823, 0.890) and 0.712 (95% CI: 0.668, 0.754) for APHE, washout and capsule, respectively. The expert-guided system significantly outperformed the end-to-end system with a LI-RADS grading accuracy of 68.3% (95% CI: 60.8%, 76.5%) vs 55.6% (95% CI: 48.8%, 63.0%) (P<0.0001). On external testing set, the accuracy of mapped diameter intervals was 91.5% (95% CI: 81.9%, 100.0%). The AUCs were 0.792 (95% CI: 0.745, 0.833), 0.654 (95% CI: 0.602, 0.703) and 0.658 (95% CI: 0.606, 0.707) for APHE, washout and capsule, respectively. The expert-guided system achieved an overall grading accuracy of 66.2% (95% CI: 58.0%, 75.2%), significantly higher than the end-to-end system of 50.1% (95% CI: 43.1%, 58.1%) (P<0.0001). CONCLUSION: We developed a semi-automatic step-by-step expert-guided LI-RADS grading system (LR-3 to 5), superior to the conventional end-to-end learning system. This deep learning-based system may improve workflow efficiency for HCC diagnosis in clinical practice. |
format | Online Article Text |
id | pubmed-8255313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-82553132021-07-06 A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI Sheng, Ruofan Huang, Jing Zhang, Weiguo Jin, Kaipu Yang, Li Chong, Huanhuan Fan, Jia Zhou, Jian Wu, Dijia Zeng, Mengsu J Hepatocell Carcinoma Original Research PURPOSE: Liver imaging reporting and data system (LI-RADS) classification, especially the identification of LR-3 to 5 lesions with hepatocellular carcinoma (HCC) probability, is of great significance to treatment strategy determination. We aimed to develop a semi-automatic LI-RADS grading system on multiphase gadoxetic acid-enhanced MRI using deep convolutional neural networks (CNN). PATIENTS AND METHODS: An internal data set of 439 patients and external data set of 71 patients with suspected HCC were included and underwent gadoxetic acid-enhanced MRI. The expert-guided LI-RADS grading system consisted of four deep 3D CNN models including a tumor segmentation model for automatic diameter estimation and three classification models of LI-RADS major features including arterial phase hyper-enhancement (APHE), washout and enhancing capsule. An end-to-end learning system comprising single deep CNN model that directly classified the LI-RADS grade was developed for comparison. RESULTS: On internal testing set, the segmentation model reached a mean dice of 0.84, with the accuracy of mapped diameter intervals as 82.7% (95% CI: 74.4%, 91.7%). The area under the curves (AUCs) were 0.941 (95% CI: 0.914, 0.961), 0.859 (95% CI: 0.823, 0.890) and 0.712 (95% CI: 0.668, 0.754) for APHE, washout and capsule, respectively. The expert-guided system significantly outperformed the end-to-end system with a LI-RADS grading accuracy of 68.3% (95% CI: 60.8%, 76.5%) vs 55.6% (95% CI: 48.8%, 63.0%) (P<0.0001). On external testing set, the accuracy of mapped diameter intervals was 91.5% (95% CI: 81.9%, 100.0%). The AUCs were 0.792 (95% CI: 0.745, 0.833), 0.654 (95% CI: 0.602, 0.703) and 0.658 (95% CI: 0.606, 0.707) for APHE, washout and capsule, respectively. The expert-guided system achieved an overall grading accuracy of 66.2% (95% CI: 58.0%, 75.2%), significantly higher than the end-to-end system of 50.1% (95% CI: 43.1%, 58.1%) (P<0.0001). CONCLUSION: We developed a semi-automatic step-by-step expert-guided LI-RADS grading system (LR-3 to 5), superior to the conventional end-to-end learning system. This deep learning-based system may improve workflow efficiency for HCC diagnosis in clinical practice. Dove 2021-06-29 /pmc/articles/PMC8255313/ /pubmed/34235105 http://dx.doi.org/10.2147/JHC.S316385 Text en © 2021 Sheng et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Sheng, Ruofan Huang, Jing Zhang, Weiguo Jin, Kaipu Yang, Li Chong, Huanhuan Fan, Jia Zhou, Jian Wu, Dijia Zeng, Mengsu A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title | A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title_full | A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title_fullStr | A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title_full_unstemmed | A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title_short | A Semi-Automatic Step-by-Step Expert-Guided LI-RADS Grading System Based on Gadoxetic Acid-Enhanced MRI |
title_sort | semi-automatic step-by-step expert-guided li-rads grading system based on gadoxetic acid-enhanced mri |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255313/ https://www.ncbi.nlm.nih.gov/pubmed/34235105 http://dx.doi.org/10.2147/JHC.S316385 |
work_keys_str_mv | AT shengruofan asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT huangjing asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zhangweiguo asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT jinkaipu asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT yangli asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT chonghuanhuan asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT fanjia asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zhoujian asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT wudijia asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zengmengsu asemiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT shengruofan semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT huangjing semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zhangweiguo semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT jinkaipu semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT yangli semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT chonghuanhuan semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT fanjia semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zhoujian semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT wudijia semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri AT zengmengsu semiautomaticstepbystepexpertguidedliradsgradingsystembasedongadoxeticacidenhancedmri |